Research Progress on the Effect of Autophagy and Exosomes on Liver Fibrosis
Authors:
- 1 July 2024
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 19 (6) , 785-797
Abstract
Chronic liver disease is a known risk factor for the development of liver cancer, and the development of microRNA (miRNA) liver therapies has been hampered by the difficulty of delivering miRNA to damaged tissues. In recent years, numerous studies have shown that hepatic stellate cell (HSC) autophagy and exosomes play an important role in maintaining liver homeostasis and ameliorating liver fibrosis. In addition, the interaction between HSC autophagy and exosomes also affects the progression of liver fibrosis. In this paper, we review the research progress of mesenchymal stem cell-derived exosomes (MSC-EVs) loaded with specific miRNA and autophagy, and their related signaling pathways in liver fibrosis, which will provide a more reliable basis for the use of MSC-EVs for therapeutic delivery of miRNAs targeting the chronic liver disease.Keywords
Funding Information
- Natural Science Foundation of Guangdong Province (2021A1515011580, 2021B1515140012, 2023A1515010083, 2022A1515011696)
- Dongguan Science and Technology of Social Development Program (20211800905342, 20221800905572)
- Administration of Traditional Chinese Medicine of Guangdong Province (20211216)
- Medical Scientific Research Foundation of Guangdong Province (A2020096, B2021330)
- Research and Development Fund of Dongguan People’s Hospital (k202005)
- Special Funds for the Cultivation of Guangdong College Students’ Scientific and Technological Innovation (pdjh2021b0224)
- Guangdong Medical University Students’ Innovation Experiment Program (2020ZZDS002, 2020ZYDS005, 2021ZZDS006, 2021ZCDS003, ZYDS003)
- Guangdong Medical University Students’ Innovation and Entrepreneurship Training Program (GDMU2020010, GDMU2020078, GDMU2021003, GDMU2021049)
- Provincial and National College Students’ Innovation and Entrepreneurship Training Program (202110571010, S202110571078, 202210571008, S202210571075)
- Guangdong Medical University-Southern Medical University twinning research team project (4SG23033G)
- Scientific Research Fund of Guangdong Medical University (GDMUZ2020009)
This publication has 96 references indexed in Scilit:
- hMSCs-derived exosome circCDK13 inhibits liver fibrosis by regulating the expression of MFGE8 through miR-17-5p/KAT2BCell Biology and Toxicology, 2022
- Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?The Journal of Pathology, 2021
- Decreased Hepatocyte Autophagy Leads to Synergistic IL‐1β and TNF Mouse Liver Injury and InflammationHepatology, 2020
- Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinomaCancer Medicine, 2020
- MiR‐20a‐containing exosomes from umbilical cord mesenchymal stem cells alleviates liver ischemia/reperfusion injuryJournal of Cellular Physiology, 2019
- Oligomeric proanthocyanidin derived from grape seeds inhibited NF-κB signaling in activated HSC: Involvement of JNK/ERK MAPK and PI3K/Akt pathwaysBiomedicine & Pharmacotherapy, 2017
- Overview of Oroxylin A: A Promising Flavonoid CompoundPhytotherapy Research, 2016
- Hepatic stellate cell is activated by microRNA-181b via PTEN/Akt pathwayMolecular and Cellular Biochemistry, 2014
- Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in miceHepatology, 2013
- Osteopontin, an Oxidant Stress Sensitive Cytokine, Up-regulates Collagen-I via Integrin αVβ3 Engagement and PI3K/pAkt/NFκB SignalingHepatology, 2011